COVID-19 / Coronavirus

Comirnaty Bivalent Vaccine Arrives in Hong Kong SAR and Macau SAR and Will Soon Be Available to the Local Residents

2022-11-28 22:59 3827

SHANGHAI, Nov. 28, 2022 /PRNewswire/ -- On November 26, 2022, Shanghai Fosun Pharma (Group) Co., Ltd.("Fosun Pharma", Stock Code: 600196.SH; 02196.HK) announced that the first batch of about 770,000 doses of the Comirnaty Original/Omicron BA.4/BA.5 bivalent vaccine (i.e. Comirnaty Original/Omicro...

TELEHEALTH USAGE IN ASIA PACIFIC FOR PEOPLE LIVING WITH HIV INCREASING, BUT DATA PRIVACY AND LACK OF PERSONAL CONTACT STILL SEEN AS A BARRIER TO WIDER USE

2022-11-28 15:00 2664

- Half of the people living with HIV (PLHIV) and individuals at-risk (IARs) surveyed in the region increased their usage of telehealth services over the past year; this is driven by the availability of new telehealth services during pandemic - Top factor impacting usage of telehealth services fo...

Mabwell Announces the U.S. FDA approval of 9MW3011 (FIC) for IND

2022-11-24 21:00 4144

SHANGHAI, Nov. 24, 2022 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced that its clinical trial application for 9MW3011 Injection used in patients with polycythemia vera was formally approved by the United States Food...

Cathay Life Insurance Co., Ltd. Honored the Inspirational Brand Award at the Asia Pacific Enterprise Awards 2022 Taiwan

2022-11-24 12:36 2816

SINGAPORE, Nov. 24, 2022 /PRNewswire/ --Enterprise Asia, the organizer of the Asia Pacific Enterprise Awards (APEA) 2022 Taiwan, is pleased to recognize 34 exemplary business leaders and enterprises acrossAsia who have demonstrated commendable dedication toward spearheadingTaiwan's economic recov...

Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by U.S. FDA

2022-11-23 19:43 3430

--The Phase I clinical trial will consist of 3 cohorts in healthy subjects, including single- and multiple-dose escalation studies and food effect study. The objective of Phase I trial is to find a right dose to move into the pivotal Phase II/III in COVID-19 patients --In antiviral cellular assa...

Professor László Tabár Joins DetectedX as the Medical Director of Breast Cancer Imaging

2022-11-21 21:00 2124

DetectedX Bolsters Executive Team with Internationally Renowned Physician, Academic and Educator to Expand Breast Imaging Educational Content on the Company's Radiology Online Learning Platform SYDNEY, Nov. 21, 2022 /PRNewswire/ -- DetectedX, leaders in intelligent interactive educational techno...

Umoja Biopharma and IASO Biotherapeutics Announce Research Collaboration to Bring Off-the-Shelf Therapies to Patients with Hematological Malignancies

2022-11-21 21:00 2212

Collaboration will bring together Umoja's iCIL platform and IASO's chimeric antigen receptors to create the next generation of broadly accessible, readily available cell therapies in indications that are significantly underserved by today's standards of care. SEATTLE, SAN JOSE, Calif., SHANGHAI ...

Immorna Receives IND Clearance to Conduct a Phase 1/2 Study of JCXH-221, a Broadly Protective mRNA-Based COVID-19 Vaccine

2022-11-21 20:00 1636

MORRISVILLE, N.C., Nov. 21, 2022 /PRNewswire/ -- Immorna, a rapidly expanding biotechnology company, focusing on the development of multi-platform RNA-based therapeutics and vaccines, today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) a...

Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals

2022-11-21 18:30 1460

VELDONA® interferon-alpha formulation has shown potential as a treatment candidate for feline chronic gingivostomatitis and canine atopic dermatitis Ainos advances its product pipeline as it targets commencing clinical studies during the second quarter of 2023 SAN DIEGO, Nov. 21, 2022 /PRNewswir...

Lianhua Respiratory Health Products to Assure the Smooth Holding of Hainan International Health Industry Expo

2022-11-21 16:42 1794

SHIJIAZHUANG, China, Nov. 21, 2022 /PRNewswire/ -- The 6th Hainan International Health Industry Expo kicked off onNovember 18th, in Haikou City, China's Hainan Province. With the theme of "Construct a Global Health System, Draw a Beautiful Future for Hainan Free Trade Port", this year's event wil...

Jiangsu Recbio Technology Co., Ltd. Increases Production For The First Phase Of Manufacturing Facility With A Maximum Annual Output Of 20 Million Doses Of Recombinant HPV 9-Valent Vaccine

2022-11-21 16:07 2407

TAIZHOU, China, Nov. 21, 2022 /PRNewswire/ --  (the "Company", together with its subsidiaries, the "Group") on voluntary basis. The board of directors of the Company (the "Board") is pleased to announce that in order to meet the rapidly growing market demand for HPV 9-valent vaccines inChina and ...

Where your days begin again: Medical Korea

2022-11-21 15:49 1561

NEW YORK and SEOUL, South Korea, Nov. 21, 2022 /PRNewswire/ -- The number of international medical tourists visiting Korea increased by 25% from 110,000 in 2020 to 140,000 in 2021 despite the impact of the COVID-19 pandemic. Medi...

MEDICA 2022 Newcomer: Scivita Medical celebrates trade show success and the strategy of "globalization"

2022-11-21 12:00 2350

DUSSELDORF, Germany, Nov. 20, 2022 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair. Scivita Medical was able to announce a strategic cooperation with FUJIFILM Europe B.V. ("Fujifilm") at this year...

PolyU researchers compile world's first "atlas" of airborne microbes that provides an important new perspective for public health research

2022-11-21 10:37 1875

HONG KONG, Nov. 21, 2022 /PRNewswire/ -- Bacteria are truly abundant across the Earth's surface, from the soil to the oceans. The microbial population of the air that surrounds us is comparatively unknown, but a research expedition led by PolyU scientists is about to change that. After nearly a d...

RVAC MEDICINES AND A*STAR TO BUILD CAPABILITIES FOR mRNA PRODUCTION IN SINGAPORE

2022-11-21 10:00 2005

SINGAPORE, Nov. 20, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered inSingapore, and the Agency for Science, Technology and Research (A*STAR) today announced...

MEDICAL CITY CEO NAMED MOST INSPIRING EXECUTIVE AT ACES AWARDS 2022

2022-11-21 09:00 2222

MANILA, Philippines, Nov. 21, 2022 /PRNewswire/ -- Dr. Eugene F. Ramos, Chief Executive Officer of The Medical City (TMC), was named one ofAsia's most inspiring executives at the Asia Corporate Excellence & Sustainability Awards (ACES) 2022. The award, created to identify successful visionaries a...

Everise Guatemala Celebrates 10 Years of Delivering Excellent Customer Experience

2022-11-19 08:45 8140

Today, its 3,800-strong champion workforce and operations power 450,000 daily customer interactions for leading healthcare, travel and logistics companies GUATEMALA CITY, Nov. 18, 2022 /PRNewswire/ -- Everise Guatemala celebrated their 10th year anniversary today, marking a decade since its conta...

GenScript takes home Executive of the Year - Biotechnology at the SBR Management Excellence Awards 2022

2022-11-18 15:23 4467

Mr. Johnson Wang has propelled the GenScript APAC team to achieve numerous milestones despite external challenges. SINGAPORE, Nov. 18, 2022 /PRNewswire/ -- Global biotechnology corporation, GenScript Asia Pacific's President, Mr.Johnson Wang bagged the Executive of the Year - Biotechnology title...

Building sustainable systems for all at Future of Healthcare Week Asia

2022-11-18 14:43 4640

* Cheong Wei Yang, deputy secretary (technology) of Singapore's Ministry of Health said pandemic preparedness relies on repurposing systems useful in the pandemic so that they can pivot back into a pandemic use when needed. * Speakers include Setiaji, Expert adviser of healthtech to the minist...

Asa Ren and G42 Healthcare Team Up to Advance Genomic Sequencing and Bioinformatics in Indonesia

2022-11-17 19:49 2814

JAKARTA, Indonesia, Nov. 17, 2022 /PRNewswire/ --  Asa Ren Pte Ltd ("Asa Ren"), a leading consumer DNA data company based inIndonesia, has announced a strategic partnership with leading UAE-based Artificial Intelligence technology company, G42 Health Care AI Holding RSC LTD ("G42 Healthcare"). Th...

1 ... 23242526272829 ... 226